Are your patients experiencing the symptoms of digital device overuse?
In the past decade, a dramatic shift has occurred in how society visualizes the world.
People now spend a majority of their day immersed in visual activity on digital devices. As a result, the increased demand on our eyes is relentless.
What Eye Care Professionals Are Saying
What Eye Care Professionals Are Saying
Trigeminal Nerve Over-Stimulation:
- Neck, shoulder, back pain
- Eye strain
- Headache
- Blurred vision
- Dry eyes
Introducing a new breakthrough technology: neurolens® System
SightSync®
SightSync® uses proprietary testing techniques and sophisticated eye tracking technology to objectively measure the amount of binocular misalignment a patient is experiencing at distance and near.
SightSync® creates a dynamic customized measurement of misalignment at 6 meters and 50 cm, analyzing all elements of ocular fusion, including:
- Heterophoria
- Vergence conditioning
- Binocular peripheral fusion
- Fixation disparity
- Accomodative convergence response
- Alternating monocular central fixation
How Is It Different from Traditional Testing?
- Objective: 100% objective. No patient or operator interaction. Sophisticated eye-tracking.
- Accurate: Measurements are calculated to the one-hundredth of a prism diopter.
- Efficient: Testing performed in less than three minutes by a technician.
- Standardization: Consistent, reproducible measurement (standard deviation is <0.8 prism diopter).
Patented Progressive Prism Lens Design
A proprietary lens technology integrating a progressive prism design in conjunction with the patient’s refractive prescription. Progressive prism technology enables practitioners to relieve binocular misalignment detected at distance, intermediate, and near in a single lens. Research indicates that over 90% of patients experience a larger misalignment when fusing at near than at distance. This progressive prism lens design may be offered as a single vision or progressive addition lens.
Clinical Results
Digital Vision Syndrome (DVS) Study
Patient Reported Symptom Relief – 90 Day
- 22 participants – inclusion criteria = Qualified as DVS sufferer by validated questionnaire
- 100% positive response to treatment at 90 days
- 86% reported DVS symptoms as “Reduced Substantially” or “Basically Gone”
Chronic Daily Headache Study
Patient Reported Symptom Relief – 90 Day
- 179 participants – inclusion criteria = refractory, end-of-line chronic headache & migraine
- 81.6% positive response to treatment at 90 days
- 54% reported headache symptoms as “Reduced Substantially” or “Basically Gone”
Proven Relief
